ADVANCED GYNECOLOGICAL MALIGNANCIES
Clinical trials for ADVANCED GYNECOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GYNECOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED GYNECOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Hard-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study is testing an experimental drug called BRY812 for women with advanced gynecologic cancers that have a specific marker called LIV-1 and have stopped responding to prior treatments. The main goal is to see if the drug can shrink tumors and to understand its safety. About…
Matched conditions: ADVANCED GYNECOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial offers hope for Tough-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study is testing a new drug called SKB518 to see if it can help control advanced gynecologic cancers like ovarian, cervical, and endometrial cancer. It will involve about 290 adults whose cancer has progressed despite prior treatments. The drug will be given alone or in comb…
Matched conditions: ADVANCED GYNECOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC